Benefits of peritoneal ultrafiltration in HFpEF and HFrEF patients
Peritoneal ultrafiltration (pUF) in refractory heart failure (HF) reduces the incidence of decompensation episodes, which is of particular significance as each episode incrementally adds to mortality. Nevertheless, there are insufficient data about which patient cohort benefits the most. The objecti...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
14 May 2020
|
| In: |
BMC nephrology
Year: 2020, Volume: 21, Pages: 1-12 |
| ISSN: | 1471-2369 |
| DOI: | 10.1186/s12882-020-01777-x |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1186/s12882-020-01777-x
|
| Author Notes: | Leonie Grossekettler, Bastian Schmack, Carsten Brockmann, Reinhard Wanninger, Michael M. Kreusser, Lutz Frankenstein, Lars P. Kihm, Martin Zeier, Hugo A. Katus, Vedat Schwenger and Andrew Remppis |
| Summary: | Peritoneal ultrafiltration (pUF) in refractory heart failure (HF) reduces the incidence of decompensation episodes, which is of particular significance as each episode incrementally adds to mortality. Nevertheless, there are insufficient data about which patient cohort benefits the most. The objective of this study was to compare pUF in HFrEF and HFpEF, focusing on functional status, hospitalizations, surrogate endpoints and mortality. |
|---|---|
| Item Description: | Gesehen am 29.07.2020 |
| Physical Description: | Online Resource |
| ISSN: | 1471-2369 |
| DOI: | 10.1186/s12882-020-01777-x |